Cross-sectional study on exhaled nitric oxide in relation to upper airway inflammatory disorders with regard to asthma and perennial sensitization

dc.contributor.authorKrantz, Christina
dc.contributor.authorAccordini, Simone
dc.contributor.authorAlving, Kjell
dc.contributor.authorCorsico, Angelo G
dc.contributor.authorDemoly, Pascal
dc.contributor.authorFerreira, Diogenes S
dc.contributor.authorForsberg, Bertil
dc.contributor.authorGarcia-Aymerich, Judith
dc.contributor.authorGíslason, Þórarinn
dc.contributor.authorHeinrich, Joachim
dc.contributor.authorJõgi, Rain
dc.contributor.authorJohannessen, Ane
dc.contributor.authorLeynaert, Bénédicte
dc.contributor.authorMarcon, Alessandro
dc.contributor.authorMartínez-Moratalla Rovira, Jesús
dc.contributor.authorNerpin, Elisabet
dc.contributor.authorNowak, Dennis
dc.contributor.authorOlin, Anna-Carin
dc.contributor.authorOlivieri, Mario
dc.contributor.authorPereira-Vega, Antonio
dc.contributor.authorRaherison-Semjen, Chantal
dc.contributor.authorReal, Francisco Gómez
dc.contributor.authorSigsgaard, Torben
dc.contributor.authorSquillacioti, Guilia
dc.contributor.authorJanson, Christer
dc.contributor.authorMalinovschi, Andrei
dc.contributor.departmentFaculty of Medicine
dc.date.accessioned2025-11-20T08:44:35Z
dc.date.available2025-11-20T08:44:35Z
dc.date.issued2022-02
dc.description.abstractBackground: Fractional exhaled nitric oxide (FeNO) is a well-known marker of type-2 inflammation. FeNO is elevated in asthma and allergic rhinitis, with IgE sensitization as a major determinant. Objective: We aimed to see whether there was an independent association between upper airway inflammatory disorders (UAID) and FeNO, after adjustment for asthma and sensitization, in a multi-centre population-based study. Methods: A total of 741 subjects with current asthma and 4155 non-asthmatic subjects participating in the second follow-up of the European Community Respiratory Health Survey (ECRHS III) underwent FeNO measurements. Sensitization status was based on measurement of IgE against airborne allergens; information on asthma, UAID and medication was collected through interview-led questionnaires. Independent associations between UAID and FeNO were assessed in adjusted multivariate regression models and test for interaction with perennial sensitization and asthma on the relation between UAID and FeNO were made. Results: UAID were associated with higher FeNO after adjusting for perennial sensitization, asthma and other confounders: with 4.4 (0.9-7.9) % higher FeNO in relation to current rhinitis and 4.8 (0.7-9.2) % higher FeNO in relation to rhinoconjunctivitis. A significant interaction with perennial sensitization was found in the relationship between current rhinitis and FeNO (p = .03) and between rhinoconjunctivitis and FeNO (p = .03). After stratification by asthma and perennial sensitization, the association between current rhinitis and FeNO remained in non-asthmatic subjects with perennial sensitization, with 12.1 (0.2-25.5) % higher FeNO in subjects with current rhinitis than in those without. Conclusions & clinical relevance: Current rhinitis and rhinoconjunctivitis was associated with higher FeNO, with an interaction with perennial sensitization. This further highlights the concept of united airway disease, with correlations between symptoms and inflammation in the upper and lower airways and that sensitization needs to be accounted for in the relation between FeNO and rhinitis. Keywords: FeNO; asthma; exhaled nitric oxide; nasal polyposis; population-based; rhinitis.en
dc.description.versionPeer revieweden
dc.format.extent15
dc.format.extent857634
dc.format.extent297-311
dc.identifier.citationKrantz, C, Accordini, S, Alving, K, Corsico, A G, Demoly, P, Ferreira, D S, Forsberg, B, Garcia-Aymerich, J, Gíslason, Þ, Heinrich, J, Jõgi, R, Johannessen, A, Leynaert, B, Marcon, A, Martínez-Moratalla Rovira, J, Nerpin, E, Nowak, D, Olin, A-C, Olivieri, M, Pereira-Vega, A, Raherison-Semjen, C, Real, F G, Sigsgaard, T, Squillacioti, G, Janson, C & Malinovschi, A 2022, 'Cross-sectional study on exhaled nitric oxide in relation to upper airway inflammatory disorders with regard to asthma and perennial sensitization', Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, vol. 52, no. 2, pp. 297-311. https://doi.org/10.1111/cea.14019en
dc.identifier.doi10.1111/cea.14019
dc.identifier.issn1365-2222
dc.identifier.other48994199
dc.identifier.other7fbdc8c6-1ae9-48a8-8d00-5c7d7f193df3
dc.identifier.otherresearchoutputwizard: hdl.handle.net/2336/622023
dc.identifier.other34536262
dc.identifier.other85116724624
dc.identifier.urihttps://hdl.handle.net/20.500.11815/6694
dc.language.isoen
dc.relation.ispartofseriesClinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology; 52(2)en
dc.relation.urlhttps://onlinelibrary.wiley.com/doi/10.1111/cea.14019en
dc.rightsinfo:eu-repo/semantics/openAccessen
dc.subjectFeNOen
dc.subjectasthmaen
dc.subjectexhaled nitric oxideen
dc.subjectnasal polyposisen
dc.subjectpopulation-baseden
dc.subjectrhinitisen
dc.subjectNitric Oxideen
dc.subjectRespiratory Tract Diseasesen
dc.subjectAsthmaen
dc.subjectFeNOen
dc.subjectasthmaen
dc.subjectexhaled nitric oxideen
dc.subjectnasal polyposisen
dc.subjectpopulation-baseden
dc.subjectrhinitisen
dc.subjectNitric Oxideen
dc.subjectRespiratory Tract Diseasesen
dc.subjectAsthmaen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.titleCross-sectional study on exhaled nitric oxide in relation to upper airway inflammatory disorders with regard to asthma and perennial sensitizationen
dc.type/dk/atira/pure/researchoutput/researchoutputtypes/contributiontojournal/articleen

Skrár

Original bundle

Niðurstöður 1 - 1 af 1
Nafn:
Clin_Experimental_Allergy_2021_Krantz_Cross_sectional_study_on_exhaled_nitric_oxide_in_relation_to_upper_airway.pdf
Stærð:
837.53 KB
Snið:
Adobe Portable Document Format

Undirflokkur